Pristinamycin IA
CAS: 3131-03-1
Rif. 3D-FP172927
| 10mg | Prezzo su richiesta | ||
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta | ||
| 250mg | Prezzo su richiesta |
Informazioni sul prodotto
- 2-pyridinecarboxamide, N-[22-[[4-(dimethylamino)phenyl]methyl]-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-12H-pyrido[2,1-f]pyrrolo[2,1-l][1,4,7,10,13,16]oxapentaazacyclononadecin-9-yl]-3-hydroxy-
Pristinamycin IA is a macrolide antibiotic that has been found to be effective against gram-positive bacteria, including Streptococcus pyogenes, S. pneumoniae, and Staphylococcus aureus. It also has synergistic effects when used with antibiotics such as tetracycline or erythromycin. Pristinamycin IA inhibits the synthesis of bacterial protein by binding to the 50S ribosomal subunit, as well as inhibiting DNA gyrase and topoisomerase IV. The discovery process for this drug was based on the observation that a mutant strain of Streptomyces coelicolor (strain A) was resistant to streptogramins. This led to the discovery that these mutants have an increased resistance to pristinamycin IA due to mutations in their 16S ribosomal RNA.
Proprietà chimiche
Richiesta tecnica su: 3D-FP172927 Pristinamycin IA
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
